Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Eiyzey
Dosage Form : Injectable Solution In Vial
Dosage Strength : 40MG
Packaging :
Approval Date : 28-08-2025
Application Number : 1251963002
Regulatory Info : Authorized
Registration Country : Spain
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Eiyzey
Dosage Form : Injectable Solution In Pre-Filled Syringe
Dosage Strength : 40MG
Packaging :
Approval Date : 28-08-2025
Application Number : 1251963001
Regulatory Info : Authorized
Registration Country : Spain
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eiyzey
Dosage Form : Injection Solution
Dosage Strength : 40mg/ml
Packaging :
Approval Date : 14-08-2025
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eiyzey
Dosage Form : Solution For Injection
Dosage Strength : 40mg/ml
Packaging :
Approval Date : 14-08-2025
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Vgenfli
Dosage Form : Injection Solution
Dosage Strength : 40mg/ml
Packaging :
Approval Date : 14-08-2025
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Vgenfli
Dosage Form : Solution For Injection
Dosage Strength : 40mg/ml
Packaging :
Approval Date : 14-08-2025
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Zaltrap
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 200mg/8ml
Packaging :
Approval Date : 2013-03-20
Application Number : 62676
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Zaltrap
Dosage Form : Concentrate For Infusion Solution
Dosage Strength : 25MG
Packaging :
Approval Date : 22-02-2013
Application Number : 112814002
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Zaltrap
Dosage Form : Concentrate For Infusion Solution
Dosage Strength : 25MG
Packaging :
Approval Date : 22-02-2013
Application Number : 112814001
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Zaltrap
Dosage Form : Concentrate For Infusion Solution
Dosage Strength : 25MG
Packaging :
Approval Date : 22-02-2013
Application Number : 112814003
Regulatory Info : Authorized
Registration Country : Spain
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dr. Paul Lohmann GmbH & Co. KGaA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CD Formulation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Thickeners and Stabilizers
Solubilizers
Surfactant & Foaming Agents
Topical
Taste Masking
Controlled & Modified Release
Coating Systems & Additives
API Stability Enhancers
Emulsifying Agents
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
FDF DOSSIERS
Reply
02 Sep 2023
Reply
14 Apr 2023
Reply
09 Jan 2023
Reply
07 Jun 2022
Reply
16 Dec 2021
Reply
06 Dec 2021
Reply
09 Dec 2020
Reply
15 Feb 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Health Canada Patents
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2024-06-04
Date Granted : 2014-01-14
Brand Name : ZALTRAP
Patent Number : 2519875
Filing Date : 2004-06-04
Strength per Unit : 100 mg / vial
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2024-06-04
Date Granted : 2014-01-14
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2020-05-23
Date Granted : 2007-08-07
Brand Name : ZALTRAP
Patent Number : 2376379
Filing Date : 2000-05-23
Strength per Unit : 100 mg / vial
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2020-05-23
Date Granted : 2007-08-07
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2025-12-02
Date Granted : 2014-08-12
Brand Name : ZALTRAP
Patent Number : 2586735
Filing Date : 2005-12-02
Strength per Unit : 100 mg / vial
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2025-12-02
Date Granted : 2014-08-12
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2020-05-23
Date Granted : 2007-08-07
Brand Name : ZALTRAP
Patent Number : 2376379
Filing Date : 2000-05-23
Strength per Unit : 200 mg / vial
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2020-05-23
Date Granted : 2007-08-07
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2024-06-04
Date Granted : 2014-01-14
Brand Name : ZALTRAP
Patent Number : 2519875
Filing Date : 2004-06-04
Strength per Unit : 200 mg / vial
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2024-06-04
Date Granted : 2014-01-14
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2025-12-02
Date Granted : 2014-08-12
Brand Name : ZALTRAP
Patent Number : 2586735
Filing Date : 2005-12-02
Strength per Unit : 200 mg / vial
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2025-12-02
Date Granted : 2014-08-12
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
Comment (4)
